Search results
Author(s):
Barbara McGowan
Added:
1 year ago
ECO 2024 — Prof Barbara McGowan (Guy's and St Thomas' Hospital & King's College, UK) joins us to discuss the findings from the STEP 10 trial (NCT05040971, Novo Nordisk).This Phase 3 randomised clinical trial investigated the efficacy and safety of subcutaneous semaglutide 2.4 mg (GLP-1 RA) in 181 participants with obesity (BMI greater than or equal to 30.0 kg/m^2) and prediabetes. The primary…
View more
Ana María Cebrián Cuenca
Job title: Family Physician and Associate Professor
Author
Obesity Management and Cardiovascular Disease
Author(s):
Miao Gao
,
Tanjot Singh
,
Ramzi Ajjan
Added:
1 month ago
Review Article
Author(s):
Yimeng Zhang
,
Nimai Desai
,
Derek Connolly
Added:
1 year ago
Frailty and Cardiovascular Risk
Author(s):
Nicholas R Evans
,
Shiv Bhakta
,
Claudia Zeicu
,
et al
Added:
1 week ago
Review Article
Obesity and CKD: The Dual Epidemic in Cardiovascular Health
Author(s):
Christopher Henry Grant
,
Samira Bell
Added:
6 months ago
Review Article
Link Between NAFLD/NASH and Cardiometabolic Syndrome
Author(s):
Sheila Gato
,
Vanessa García-Fernández
,
Antonio Gil-Gómez
,
et al
Added:
2 years ago
Review Article